Tasmia Pharmaceuticals Limited in Bristol, BS5 0PS

Description

Data updated on: 01-11-2023

Tasmia Pharmaceuticals Limited was set up as Private Limited Company, that is located in 116 Stapleton Road, Bristol. The headquarters' zip code is BS5 0PS. The company has existed fourteen years on the British market. The registered no. is 07373967. The firm's declared SIC number is 86900, that means Other human health activities. Tasmia Pharmaceuticals Ltd released its account information for the period up to 2022-10-31. The most recent annual confirmation statement was submitted on 2023-06-30.

At the moment, there is a single director in the company: Nadeem Y. (since 2010-09-13). This firm had been managed by Sughra B. until 2011. Additionally a different director, including Barbara K. quit in 2010.

Nadeem Y. is the individual who controls this firm, owns over 3/4 of company shares and has 3/4 to full of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-10-31	2012-10-31	2018-10-31	2019-10-31	2020-10-31	2021-10-31	2022-10-31	2023-04-30
Currency
Net Worth	10 840	14 310

Balance Sheet
Cash Bank On Hand			67	9 889	8 028	2 104	630	630
Current Assets	45 114	74 108	46 359	76 103	82 847	67 790	112 132	76 440
Debtors	25 740	37 265	41 506	35 906	46 760	37 627	71 502	35 810
Net Assets Liabilities			36 545	73 778	111 431	124 485	132 690	110 533
Other Debtors			41 506	35 906	46 760	37 627	71 502	35 810
Property Plant Equipment			1 178	1 001	851	723	614	568
Total Inventories			4 786	30 308	28 059	28 059	40 000	40 000
Cash Bank In Hand	918	24 017
Intangible Fixed Assets	180 000	180 000
Net Assets Liabilities Including Pension Asset Liability	10 840	14 310
Stocks Inventory	18 456	12 826
Tangible Fixed Assets	2 406	2 045

Capital & Reserves
Called Up Share Capital	2	2
Profit Loss Account Reserve	10 838	14 308
Shareholder Funds	10 840	14 310

Other Financial Data
Accumulated Depreciation Impairment Property Plant Equipment			2 732	2 909	3 059	3 187	3 296	3 342
Average Number Employees During Period			6	6	6	10	7	6
Bank Borrowings Overdrafts			29 983	38 789	10 000	10 000	38 746	39 065
Comprehensive Income Expense			24 913	39 048	39 838	15 054	8 205	-22 157
Corporation Tax Payable			7 415	13 317	14 809	9 632	10 332	5 441
Creditors			190 992	183 326	112 267	85 695	131 723	123 142
Depreciation Rate Used For Property Plant Equipment				15		15	15	15
Dividends Paid			23 500	2 000	2 000	2 000
Fixed Assets	182 406	182 045	181 178	181 001	180 851	180 723	180 614	180 568
Income Expense Recognised Directly In Equity			-23 500	-2 000	-2 000	-2 000
Increase From Depreciation Charge For Year Property Plant Equipment				177		128	109	46
Intangible Assets			180 000	180 000	180 000	180 000	180 000	180 000
Intangible Assets Gross Cost			180 000	180 000	180 000	180 000	180 000	180 000
Net Current Assets Liabilities	-171 566	-167 735	-144 633	-107 223	-29 420	-17 905	-19 591	-46 702
Other Creditors			127 816	113 755	68 675	46 213	43 736	13 290
Other Taxation Social Security Payable					323	5 522	5 487	5 487
Pension Other Post-employment Benefit Costs Other Pension Costs				1 068	940	1 067	905	1 148
Profit Loss			24 913	39 048	39 838	15 054	8 205	-22 157
Property Plant Equipment Gross Cost				3 910		3 910	3 910	3 910
Staff Costs Employee Benefits Expense			33 974	77 343	92 460	101 599	49 890	25 076
Total Assets Less Current Liabilities	10 840	14 310	36 545	73 778	151 431	162 818	161 023	133 866
Trade Creditors Trade Payables			25 778	17 465	18 460	14 328	33 422	59 859
Wages Salaries			33 974	76 275	91 520	100 532	48 985	23 928
Advances Credits Directors			127 816	111 172	57 361	42 823	11 592	5 088
Advances Credits Made In Period Directors					53 811	14 538	31 231
Advances Credits Repaid In Period Directors			127 816
Creditors Due Within One Year	216 680	241 843
Intangible Fixed Assets Cost Or Valuation	180 000	180 000
Tangible Fixed Assets Cost Or Valuation	2 831	2 831
Tangible Fixed Assets Depreciation	425	786
Tangible Fixed Assets Depreciation Charged In Period		361

Company staff

Nadeem Y.

Role: Director

Appointed: 13 September 2010

Latest update: 11 February 2024

Sughra B.

Role: Secretary

Appointed: 01 June 2011

Resigned: 01 October 2014

Latest update: 11 February 2024

Sughra B.

Role: Director

Appointed: 04 November 2010

Resigned: 01 June 2011

Latest update: 11 February 2024

Barbara K.

Role: Director

Appointed: 13 September 2010

Resigned: 13 September 2010

Latest update: 11 February 2024

People with significant control

Nadeem Y.

Notified on 1 July 2016

Nature of control:

over 3/4 of shares

3/4 to full of voting rights

Accounts Documents

Account next due date	31 January 2024
Account last made up date	31 October 2022
Confirmation statement next due date	14 July 2024
Confirmation statement last made up date	30 June 2023

Annual Accounts 26 March 2013
Start Date For Period Covered By Report	2011-11-01
End Date For Period Covered By Report	2012-10-31
Date Approval Accounts	26 March 2013
Annual Accounts
Start Date For Period Covered By Report	2018-11-01
End Date For Period Covered By Report	31/10/2019
Annual Accounts
Start Date For Period Covered By Report	2020-11-01
End Date For Period Covered By Report	31/10/2021
Annual Accounts
Start Date For Period Covered By Report	2021-11-01
End Date For Period Covered By Report	31/10/2022
Annual Accounts
Start Date For Period Covered By Report	01/11/2022
End Date For Period Covered By Report	30/04/2023

Tasmia Pharmaceuticals Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Nadeem Y.

Sughra B.

Sughra B.

Barbara K.

People with significant control

Nadeem Y.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies